14th August 2019
Improving drug safety with a centralised and digital system
MEDIKURA is building the digital infrastructure for drug safety in order to help patients cope with side-effects, enable more targeted therapies, and accelerate data-driven drug discovery. The company streamlines the process of capturing, communicating, and analysing side-effect data through a cloud-based platform that connects pharma companies with patients, pharmacists and doctors. Pictured: MEDIKURA Founding Team: Tobias Nendel, Friderike Bruchmann, Dr. Philipp Naegelein
The goal is to replace the decentralised analogue drug-safety process with a centralised and digital system. MEDIKURA’s goal is address the societal problem which indicates that more than 200 000 European citizens die from Adverse Drug Reactions (ADR) every year, whereas less than 1% of ADR cases are officially reported by patients and doctors.
They closed their first financing round and received public grants worth €200 000, the most recent one being the “SME Instrument Phase 1 Grant” by the European Commission. In June 2018, MEDIKURA was awarded the “Bayerischer Innovationspreis Gesundheitstelematik” which recognises selected digital start-ups improving healthcare infrastructure at large.
MEDIKURA is one of the successful examples for the transition of Campus alumni into the Accelerator. Friderike Bruchmann participated in a CDTM Trendseminar in 2017 and got in touch with our Business Creation Manager Eva-Maria Markutzik to learn how she could push her business idea forward with the help of EIT Health.
At the beginning of 2018, the team and CEO Friderike Bruchmann received the EXIST funding by the German Ministry of Economics to launch their start-up project from the Center for Digital and Technology Management in Munich. In addition to that, the team was invited to the European Parliament during the 9th European Innovation Summit as the EU Top 50 of the Hemicycle Start-up Convention.
The complete article about these milestones can be found here.
Find out more about Medikura:
For further enquiries contact:
Philipp Nägelein, firstname.lastname@example.org
AI tool for COVID-19 produces significant results
EIT Health project aids personalised medicine
EIT Health helps Tubulis secure €10.7M in funding
Investor Network aids firm doing antibody work
EIT Health-backed start-ups garner big investments
A million each for iLoF and Restorative Neurotechnologies